Related Experiment Video
Updated: Jul 20, 2026
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
G-CSF in acute myocardial infarction - experimental and clinical findings
Hüseyin Ince1, Michael Petzsch, Tim C Rehders
1Department of Medicine, Division of Cardiology, University Hospital Rostock, Rostock School of Medicine, Rostock, Germany. hueseyin.ince@med.uni-rostock.de
Insights
Granulocyte-colony stimulating factor (G-CSF) shows promise for treating acute myocardial infarction by mobilizing stem cells. This approach offers a less invasive method for improving heart remodeling and perfusion post-heart attack.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Stem Cell Therapy
Background:
- Intracoronary progenitor cell injection shows potential for post-infarction recovery.
- Mobilization of stem cells via G-CSF offers advantages over direct infusion.
- G-CSF provides a noninvasive method for stem cell mobilization.
Purpose of the Study:
- To review experimental and clinical findings on G-CSF treatment for acute myocardial infarction.
- To highlight the benefits of G-CSF in stem cell mobilization for cardiac repair.
Main Methods:
- Review of current experimental data on G-CSF.
- Analysis of clinical study findings regarding G-CSF in myocardial infarction.
- Focus on autologous bone marrow mononuclear CD34+ cells (MNCCD34+) mobilization.
Main Results:
- Early studies indicate G-CSF aids in post-infarction remodeling and perfusion.
- Subcutaneous G-CSF injections offer a noninvasive route for stem cell mobilization.
- G-CSF treatment is an emerging strategy in acute myocardial infarction management.
Conclusions:
- G-CSF holds significant therapeutic potential for acute myocardial infarction.
- Noninvasive stem cell mobilization by G-CSF is a promising advancement.
- Further research into G-CSF therapy for cardiac repair is warranted.
Abstract:
Early data from clinical studies suggest that intracoronary injection of autologous progenitor cells may beneficially affect postinfarction remodeling and perfusion. Beyond intracoronary infusion of autologous bone marrow mononuclear CD34+ cells (MNCCD34+), mobilization of stem cells by G-CSF has recently attracted attention because of various advantages such as the noninvasive nature of MNCCD34+ mobilization by subcutaneous injections. It is the aim of the present work to give an overview about the current experimental and clinical findings of G-CSF treatment in acute myocardial infarction.
Related Concept Videos
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:30Acute Coronary Syndrome I: Introduction
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...